visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Senhwa Biosciences

    Get Full Access

    Description

    • Senhwa Biosciences, Inc. (Senhwa) is a drug development company. It is engaged in development of small molecule drugs for treating newly validated targets in cancer pathways. Its pipeline product portfolio includes two agents in clinical development for cancer, namely, CX-5461 and CX-4945. Senhwas CX-5461 is a p53 activating Pol I inhibitor and a lead anticancer compound for treating hematological malignancies; and CX-4945 is a small molecule CK2 inhibitor that treats patients with solid tumors cancer cells. The company has alliances with companies such as Panlabs Biologics, D Lab, Inc., Development Center for Biotechnology, Lexcel Partners and CDIB Bio Science Venture Management. It has its operational presence in the US. Senhwa is headquartered in New Taipei City, Taiwan.
    • location

      Headquarters:10509 Vista Sorrento Parkway Suite 201, San Diego, California, United States

      More
    • Senhwa Biosciences phone

      Phone Number: +1 858-552-6808

    • Senhwa Biosciences website

      Website: https://www.senhwabio.com

    • Senhwa Biosciences employees

      Employees:29

    • Senhwa Biosciences revenue

      Revenue:$10 - 50M

    • Senhwa Biosciences legal name

      Legal Name:Senhwa Biosciences

    • Senhwa Biosciences's Social Media

      Senhwa Biosciences linkedin
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Senhwa Biosciences

    Taisen Soong

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    John Soong

    Chief Medical Officer

    Joson Hsiao

    Legal And Ip Executive Manager, President Office

    Olga Titova

    Medical Director

    Chang Sarah

    Director

    Bini

    Manager Quality Assurance - Head Of Quality

    Frequently Asked Questions regarding Senhwa Biosciences

    • Where are Senhwa Biosciences's Headquarters?

      Senhwa Biosciences's Headquarters are in 10509 Vista Sorrento Parkway Suite 201,San Diego,California,United States

    • What is Senhwa Biosciences's phone number?

      Senhwa Biosciences's phone number is +1 858-552-6808

    • What is Senhwa Biosciences's official website?

      Senhwa Biosciences's official website is https://www.senhwabio.com

    • What is Senhwa Biosciences's Revenue?

      Senhwa Biosciences's revenue is $10 - 50M

    • What is Senhwa Biosciences's NAICS code?

      Senhwa Biosciences's NAICS code is 541713

    • How many employees are working in Senhwa Biosciences

      Senhwa Biosciences has 29 employees

    • What is Senhwa Biosciences's Industry?

      Senhwa Biosciences is in the industry of Biotechnology

    • Who is Senhwa Biosciences's CEO?

      Senhwa Biosciences's CEO is Taisen Soong

    Company Directory